Zoll was recently been cleared by the FDA for a new E Series defibrillator with CO2 Monitor. The new product is designed to detect carbon monoxide (CO2) poisoning with the push of a button, enabling early treatment. The E Series features a see-through CPR filter, Real CPR Help for real-time feedback of chest compressions, and wireless 12-lead transmission.
Last August, Zoll received approval from the FDA to sell a new LifeVest defibrillator.
Chicago Residents are now debating whether the availablity of a defibrillator on the Chicago Metra Train might have saved a man that died from cardiac arrest on October 9th, 2009.
Two nurses rushed to assist Metra crew members who tried to help the 63-year-old Barrington Hills man with heart attack symptoms. They attempted CPR. Emergency responders who met the train at the Palatine station also tried to save the man, but died.
The tragic story quickly raised questions among some regular passengers and medical authorities, who questioned why the Metra trains, unlike passenger airplanes, don’t have defibrillators on board. It also came to light that neither the CTA buses and trains have them available.
Defibrillators are becoming more common on mass transit systems, not just in the United States but all over the world. Why a major transportation system like the Metra has thus far failed to provide AED remains a mystery.
What do you think?
The FDA announced that some Physio-Control Automated External Defibrillators from the Lifepak CR Plus line are being recalled due to possible inoperability in extremely humid conditions. This could be a serious problem for those that live in humid states or where the units have been deployed where humidity might be high. It would be best to contact Physio-Control to find out more information about your particular unit or if you need to have your unit replaced.
Zoll Medical, one of the makers of Defibrillator products announced today that the U.S. Food and Drug Administration has approved a new version of it’s LifeVest product. The Zoll LifeVest is worn by patients at risk for sudden cardiac arrest. Zoll said more than 2,000 patients are currently using the product. Zoll said it is increasing its inventory to support further growth.
The LifeVest is mainly worn by those of very high-risk of having cardiac arrest!
The LifeVest is worn outside of the body rather than having to be implanted in the chest. Reasons could be for the risk of surgery or patient preference.
The Zoll LifeVest consist of two main pieces to the defibrillator:
An electrode belt and garment that surrounds the patient’s chest and A monitor the patient puts around their waist or wears as a shoulder strap.
For more information see: Zoll LifeVest.
